Threshold-awareness in adaptive cancer therapy

Authors

Abstract

Although adaptive cancer therapy shows promise in integrating evolutionary dynamics into treatment scheduling, the stochastic nature of cancer evolution has seldom been taken into account. Various sources of random perturbations can impact the evolution of heterogeneous tumors, making performance metrics of any treatment policy random as well.
In this paper, we propose an efficient method for selecting optimal adaptive treatment policies under randomly evolving tumor dynamics. The goal is to improve the cumulative "cost" of treatment, a combination of the total amount of drugs used and the total treatment time. As this cost also becomes random in any stochastic setting, we maximize the probability of reaching the treatment goals (tumor stabilization or eradication) without exceeding a pre-specified threshold (or a "budget"). We use a novel Stochastic Optimal Control formulation and Dynamic Programming to find such "threshold-aware" optimal treatment policies. Our approach enables an efficient algorithm to compute these policies for a range of threshold values simultaneously.
Compared to treatment plans shown to be optimal in a deterministic setting, the new "threshold-aware" policies significantly improve the chances of the therapy succeeding under the budget, which is correlated with a lower general drug usage. We illustrate this method using two specific examples, but our approach is far more general and provides a new tool for optimizing adaptive therapies based on a broad range of stochastic cancer models.

Paper

View manuscript on bioRxiv »

Source Code

Examples

Convergence Plots

Acknowledgements

The authors would like to acknowledge Mark Gluzman, Artem Kaznatcheev, Robert Vander Velde, and David Basanta for inspiring our work. The authors are grateful to Roberto Ferretti and Lars GrĂ¼ne for their advice on some aspects of numerical methods used in this project. The authors also thank Mallory E. Gaspard, Cole Miles, and Elliot Cartee for providing the website template.

The 1st and 3rd authors' work is supported by the National Science Foundation (DMS-1645643, DMS-1738010, and DMS-2111522). The 2nd author's work is supported by the National Cancer Institute (R37 CA244613) and the American Cancer Society through their Research Scholar Grant (132691-RSG-20-096-01).